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Abstract: A Near Infrared Spectral Tomography (NIRST) system has been 
developed and integrated into a commercial Digital Breast Tomosynthesis 
(DBT) scanner to allow structural and functional imaging of breast in vivo. 
The NIRST instrument uses an 8-wavelength continuous wave (CW) laser-
based scanning source assembly and a 75-element silicon photodiode solid-
state detector panel to produce dense spectral and spatial projection data 
from which spectrally constrained 3D tomographic images of tissue 
chromophores are produced. Integration of the optical imaging system into 
the DBT scanner allows direct co-registration of the optical and DBT 
images, while also facilitating the synergistic use of x-ray contrast as 
anatomical priors in optical image reconstruction. Currently, the total scan 
time for a combined NIRST-DBT exam is ~50s with data collection from 8 
wavelengths in the optical scan requiring ~42s to complete. The system was 
tested in breast simulating phantoms constructed using intralipid and blood 
in an agarose matrix with a 3 cm x 2 cm cylindrical inclusion at 1 cm depth 
from the surface. Diffuse image reconstruction of total hemoglobin (HbT) 
concentration resulted in accurate recovery of the lateral size and position 
of the inclusion to within 6% and 8%, respectively. Use of DBT structural 
priors in the NIRST reconstruction process improved the quantitative 
accuracy of the HbT recovery, and led to linear changes in imaged versus 
actual contrast, underscoring the advantages of dual-modality optical 
imaging approaches. The quantitative accuracy of the system can be further 
improved with independent measurements of scattering properties through 
integration of frequency or time domain data. 
©2012 Optical Society of America 
OCIS codes: (120.3890) Medical optics instrumentation; (170.4580) Optical diagnostics for 
medicine; (170.6510) Spectroscopy, tissue diagnostics; (170.7440) X-ray imaging. 
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1. Introduction 
Digital Breast Tomosynthesis (DBT) is an emerging FDA-approved imaging modality for 
breast cancer screening [1–3]. The technique is similar to conventional mammography in that 
it images variations in breast density using x-ray attenuation and requires significant 
compression to enhance soft tissue contrast. Importantly, DBT extends the capabilities of 
conventional mammography by acquiring x-ray projection data at a limited set of angular 
views, which allows 3D reconstruction of tissue density over the imaged breast volume. The 
concept is related to conventional Computed Tomography (CT), but with limited angular 
sampling. DBT provides superior lateral resolution, but its depth discrimination is relatively 
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poor (typically about 1 mm resolution) because of the restricted angular views, which also 
can cause artifacts such as ghosting. Nevertheless, DBT provides depth-resolved 3-D 
structural images of the breast at a dose comparable to digital mammography, but with 
improved diagnostic power [4]. 
Near Infrared Spectral Tomography (NIRST) acquires optical projection data at multiple 
wavelengths for reconstruction of functional parameters such as hemoglobin concentration, 
tissue oxygenation, fat content and water fraction, which are known to be sensitive to 
neoplastic changes in tissue. Since light transport in this regime is dominated by scattering, 
NIRST images are diffuse and lack high-resolution spatial detail, but when viewed in 
conjunction with a high resolution structural imaging modality, can provide complementary 
physiologic information to potentially improve overall diagnostic accuracy. This general 
approach of combining a structural imaging modality with a functional imaging technique has 
gained significant traction in recent years with several dual modality approaches being 
developed and tested clinically including optical imaging combined with MRI, Ultrasound, 
Mammography and DBT [5–9]. The most clinically successful implementation of dual 
modality imaging has been the combination of Positron Emission Tomography and Computed 
Tomography (PET-CT), where lower resolution PET imaging provides functional contrast to 
supplement higher resolution structural CT. 
In this study, NIRST is integrated into a commercial DBT system to allow tomographic 
recovery of hemoglobin parameters in local regions of the breast. The combined NIRST-DBT 
platform can provide co-registered functional information that could be synergistically 
interpreted with the DBT images to improve diagnostic accuracy. In particular, NIRST 
images could improve specificity in delineating malignant from benign masses, which is 
relatively difficult in women with dense breasts, and leads to the high false positive rates 
currently observed in mammography and DBT. The combination of NIRST and DBT was 
first developed at the Massachusetts General Hospital (MGH) [8]. In a recently published 
study, the MGH system examined 125 women and the results showed statistically significant 
differences in hemoglobin concentration in malignant versus benign masses relative to the 
fibroglandular region in the same breast [7]. The system consisted of an array of optical 
fibers, which deliver and collect light from discrete locations on the top and bottom surfaces 
of the compressed breast. Both continuous wave (CW, 3 wavelengths) and frequency domain 
(FD, 2 wavelengths) projection measurements were made to allow tomographic 
reconstruction of functional optical images. While the MGH design is effective, it is complex, 
expensive and not readily scalable. The NIRST-DBT system described here takes a different 
design approach, which is cost-effective, offers better integration with DBT and is simpler to 
implement. The focus is primarily on CW imaging based on tomographic projection 
measurements acquired at multiple wavelengths with provisions for adding limited FD 
recordings optimized to the design. Other breast-imaging approaches with a similar emphasis 
on CW imaging with solid-state detectors have been developed in the recent years [10,11]. 
2. Materials and methods 
2.1 NIRST system instrumentation 
The NIRST system was fabricated to attach to a commercial Digital Breast Tomosynthesis 
scanner (Genesis Dimensions, Hologic Inc., CT). A schematic of the NIRST system 
components is shown in Fig. 1(a). The source module is comprised of eight fiber-coupled, 
temperature controlled laser diode units (Power Technology, NY) with individual emission 
wavelengths at 660, 785, 808, 830, 852, 905, 915 and 940 nm. These specific wavelengths 
were selected for spectral un-mixing of oxy-hemoglobin, de-oxy hemoglobin, water and fat 
absorption spectra from combined measurements [12,13]. Each microprocessor-controlled, 
temperature-stabilized laser unit is individually addressable through a standard RS-232 
communication protocol. 
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Fig. 1. (a) Schematic of the NIRST/DBT imaging system. (b) Photograph of the fully 
assembled NIRST/DBT system installed at the Dartmouth-Hitchcock Medical Center 
(DHMC). (c) Photograph showing the silicon photodiode detector panel inserted into the 
custom designed cassette assembly to allow easy insertion and removal of the panel during 
sequential DBT/NIRST scans. (d) Photograph of the 2- axis galvanometric scanning mirror 
assembly mounted adjacent to the x-ray emission port on the DBT scanner. The source unit 
allows arbitrary positioning and scanning of laser light beams onto the compressed breast 
surface without obstructing the x-ray field-of-view. 
A USB to 8-port RS-232 adapter (CPS) allowed a single USB port on the instrument 
computer to control the operating parameters of the eight lasers. Two-hundred micron core 
diameter multimode optical fibers were used to couple light from individual lasers into a 9x1 
piezoelectric fiber optic switch (FSM 9x1-200, OptoJena, MA), which allowed fast sequential 
switching of the lasers into a single 200 micron core diameter output optical fiber. The output 
optical fiber is coupled into a computer controlled fiber optic attenuator (DD-100 series, 
OzOptics, Canada), which adaptively attenuates the light output appropriately to differences 
in attenuation properties between individual breasts. The output from the attenuator is 
coupled to a fiber optic collimator (FC) to produce a collimated beam of light of 
approximately 5mm in diameter, which diverges slightly due to the finite size of the source 
optical fiber. A pair of orthogonally mounted galvanometric scanners (GS) with 5mm scan 
mirrors (Cambridge Systems, MA) is used to direct and scan this beam over the surface of the 
breast through the transparent polycarbonate compression paddle (TCP) of the DBT system as 
shown in Fig. 1(a), resulting in a source-light spot diameter at the imaging plane of 
approximately 8 mm. The source assembly containing the FC and GS is permanently 
mounted beside the x-ray port on the DBT such that it does not interfere with DBT exposures. 
The independently controlled scanners allow arbitrary positioning of the source beam over the 
top surface of the compressed breast, but a standard raster scanning pattern was used in all 
experiments described in this work. 
The detector panel (DP) consisting of a matrix of 75 large-area silicon photodiodes was 
custom fabricated. The individual photodiode units (S9270, Hamamatsu Corp., Japan) have 
1cm x 1cm active areas with high gain transimpedance amplifiers built into each diode 
package. The diode is configured to produce 0-10 V signal range, which is digitized directly 
using a standard off-the-shelf 80-channel Analog-to-Digital Converter (ADC, USB-6255, 
National Instruments, TX), without the need for additional signal conditioning. A custom 
printed circuit board (PCB) was designed to interface the photodiode outputs to the analog 
input channels of the ADC through a pair of 68-pin standard Small Computer System 
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Interface (SCSI) connectors. A six-layer PCB design was used to isolate the power, signal, 
and ground planes to minimize noise coupling. A single −10V-0-10V dual mode linear power 
supply (Acopian, US) was used to power the detectors. Since the photodiodes were driven 
from a single power supply, 0.1µF ceramic decoupling capacitors were included to isolate 
individual photodiodes from transient loading effects and power-line fluctuations. Noise floor 
measurements indicated that the detector panel offers a full-scale dynamic range of 
approximately 51 dB. 
Since the detector panel is not transparent to x-rays, simultaneous NIRST/DBT imaging is 
not possible at this time. Hence, imaging is performed sequentially, where the detector panel 
is inserted into the field-of-view during the optical scan and removed during the DBT scan. 
To facilitate panel insertion/removal, a custom-designed detector cassette assembly (DC) was 
fabricated into the DBT base plate to allow the detector panel to slide in and out of the field 
without altering the breast position. The cassette was also designed to allow the detector panel 
to be inserted from either side of the scanner to accommodate left or right breast imaging. A 
photograph of the detector panel inserted into the cassette assembly is shown in Fig. 1(c). 
2.2 Data pre-processing and calibration 
The response of individual silicon sensors in the detection panel to a uniform field of light 
was measured to characterize differences in sensitivity. Since the detectors were mounted on 
a panel, a special calibration puck was designed to expose each of the detector units to a 
uniform field of light and record the corresponding voltage signal. The calibration puck 
consisted of an optical fiber light source coupled to a homogeneous diffuse resin phantom 
with a raised square notch machined on the top surface that allowed precise, repeatable 
alignment of this surface with the active area of the exposed detector. 
A schematic of the measurement configuration and the calibration puck are shown in Figs. 
2(a) and 2(b), respectively. Three individual measurements were made on each detector by 
removing and re-inserting the calibration puck and the average response was used for 
calibration. Detector number 5 was arbitrarily chosen as the reference and the signal strengths 
from the other sensors were referenced to its value to obtain a correction factor for the 
individual detectors. Figure 2(c) shows a plot of the correction factor for each of the 80 
detectors characterized. No correction factors were needed on the source side as the 
differences in source strengths across the entire imaging field were measured and found to be 
negligible. 
In a typical data collection sequence, measurements from all detectors were recorded for 
each source position. The data acquisition system used a front-end 80x1 analog multiplexer to 
digitize all the 75 measurement channels sequentially (5 ADC channels are left unused). 
While this analog multiplexing scheme leads to simple and cost-effective data acquisition, it 
is prone to isolation artifacts, where a high voltage signal on a particular channel could 
corrupt measurements in an adjacent channel carrying a low voltage signal. These 
inaccuracies were detected and eliminated automatically by analyzing relative signal strengths 
in all adjacent channel pairs and applying an empirical threshold determined from a series of 
homogeneous phantom measurements. An overall path-length threshold was also used to 
exclude noisy data from detectors that were far from the illumination source position. 
Currently, for a homogeneous 260 x 180 x 60 mm test phantom (BioMimic, Institut national 
d'optique, Canada) with µa = 0.01 mm
−1 and µs’ = 1 mm
−1 at 830 nm, a path-length limit of 
100 mm is used, which corresponds to lateral distances of up to 80 mm from directly beneath 
the source position. Figure 2(d) shows the raw data measured from the test phantom at 660 
nm and 785 nm wavelengths and the processed data used for image reconstruction is shown 
in Fig. 2(e). 
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Fig. 2. (a) Schematic showing the calibration puck positioned over an individual detector 
element in the detector panel. (b) Schematic drawing of the calibration puck showing a square 
notch on top that allows repeatable positioning over each detector element. (c) Correction 
factor for each of the 75 detector elements showing variations in individual detector response 
(certain detector channel numbers are unused). (d) Raw tomographic projection data plotted as 
a function of source-detector separation acquired from a homogeneous test phantom at 660 nm 
and 785 nm wavelengths. (e) Processed data showing the removal of signal artifacts. 
2.3 Measurement geometry and co-registration 
Co-registration of the optical scan with the DBT field is achieved by using the DBT 
compression paddle (CP) as a common frame of reference. The optical beam is incrementally 
scanned in the X and Y directions in 2 cm intervals. Since the height of the compression 
paddle changes for every patient, the scan angles are adjusted automatically, using simple 
trigonometry calculations, to preserve the scan geometry at any given height of the 
compression paddle. The optical scan position accuracy was verified manually with a 
rectangular grid pattern of 2 cm x 2cm spacing overlaid on the top compression paddle. The 
phantoms were placed at a known fixed position relative to the detector panel, which allowed 
calculation of the individual detectors positions. 
2.4 Blood-intralipid phantom preparation and imaging 
Breast tissue simulating intralipid and blood phantoms were created in an agarose matrix. 
Type 1 agarose powder was mixed in phosphate buffered saline (PBS) at a ratio of 0.02 g/ml 
and heated in a microwave oven to bring the solution to a rolling boil. An appropriate 
quantity of 20% intralipid solution pre-mixed to achieve 1% volume fraction of lipids overall 
was added to the PBS-agarose stock solution and the mixture was transferred to a stir plate, 
where it was continuously stirred until it cooled to ~38°C. Porcine blood was then added to 
this mixture at an appropriate dilution to achieve ~15 uM hemoglobin concentration overall. 
This mixture was stirred for a minute and then transferred into a mold for casting. The 
mixture was refrigerated for approximately 30 minutes in the mold and then removed for 
measurements. The concentration of intralipid and hemoglobin used here results in optical 
properties comparable to that of a typical breast. For fabricating inclusions, a cylindrical tube 
with a flat covered base was suspended to a predetermined depth at the position of interest, 
before the mixture began solidifying. The tube was removed after the phantom solidified to 
leave a cylindrical hole, which was filled with liquid contrast inclusions. 
A homogeneous 24 cm x 16 cm x 5.2 cm block of solid phantom and an inclusion 
phantom with the same overall dimensions were cast with the same background optical 
properties using the procedure described above. The cylindrical inclusion measured 
approximately 3 cm in diameter and 2 cm in depth and its center was located 7 cm from the 
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bottom edge and 8.4 cm from the left edge of the phantom block as shown in the schematic in 
Fig. 3(a). An additional 24 cm x 16 cm x 1 cm block was cast to act as a stacking layer, which 
when placed on the inclusion phantom positioned the heterogeneity 1 cm below the top 
surface. This stacked phantom design also allowed the top layer to be easily removed, which 
facilitated the creation of liquid inclusions with different hemoglobin and lipid contrast values 
relative to the homogeneous background. Photographs of the homogeneous top layer and 
inclusion phantom casts are shown in Fig. 3(b). The overall thickness of the phantom was 6.2 
cm, which is representative of typical maximum breast thicknesses achieved through 
compression during mammography exams [14]. 
 
Fig. 3. (a) Schematic of the intralipid/blood inclusion phantom construct which is 24 cm (in the 
X-direction) by 16 cm (in the Y-direction) by 5.2 cm (in the Z-drection). (b) Photographs of 
the fabricated top and bottom layers of the phantom and the addition of a liquid inclusion. 
Liquid inclusions with hemoglobin contrasts of 2:1, 3:1 and 4:1 were imaged relative to 
the background hemoglobin concentration of 15 µM. A 1% intralipid stock solution was used 
in all cases, fixing the scatter contrast to 1:1. A homogeneous phantom measurement was 
obtained by filling the inclusion with 1% intralipid stock solution containing 15 µM of 
hemoglobin matching the absorption and scatter properties of the background. The 
homogeneous phantom measurements served as a calibration for the contrast phantom data 
and account for variations in source strengths across the measured wavelengths [15–17]. The 
eight-wavelength scan time for each phantom was approximately 42s. 
2.5 NIRST image reconstruction 
The NIRFAST software package version 7 was used to reconstruct the chromophore images 
directly with a spectrally constrained inversion algorithm [18]. Its finite element method 
(FEM) image reconstruction process is described in detail elsewhere [19]. FEM meshes 
representing the homogeneous and contrast phantoms were created with a 3-D meshing 
algorithm developed in-house. Three-dimensional (3D) diffuse reconstruction of total 
hemoglobin concentration was performed from data on 2:1, 3:1 and 4:1 contrast phantoms. 
Images of total hemoglobin concentration (HbT), oxygenation, water fraction and fat content 
were recovered from the experimental data calibrated with the reference phantom 
measurements. 
The diffuse reconstruction process is ill posed often leading to poor quantitative accuracy 
of the recovered contrast. Another approach to reconstructing the chromophore contrast 
applies prior knowledge of the size and location of the heterogeneity in the reconstruction 
problem to recover chromophore concentrations from these pre-defined “regions-of-interest” 
[20]. The region-guided approach provides better quantitative accuracy through reduced 
dimensionality of the inverse problem, but also assumes optical property homogeneity within 
the defined regions. The method is known to improve diagnostic performance in multi-
modality imaging frameworks, such as the NIRST-DBT system described here, where 
accurate anatomic information is available [20]. 
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3. Results 
3.1 NIRST-DBT system performance 
Table 1 summarizes key performance metrics of the NIRST-DBT system. The dynamic range 
of the detection panel was calculated from the measurements of the maximum and minimum 
signal levels that could be detected. The maximum dynamic range offered by the detection 
panel was ~59.6 dB. However in the presence of other noise sources the effective dynamic 
range is reduced to about ~50.1 dB. Table 1 also shows signal to noise ratio (SNR) values for 
a typical source-detector projection measurement producing a nominal signal range of ~1-2V. 
This metric was computed from the mean and standard deviation of 5 independent, calibrated 
projection measurements made on a homogeneous phantom, to provide an assessment of the 
overall fidelity of the raw measured signals. 
Table 1. Key Performance Parameters of the NIRST-DBT System 
Parameter Value 




dynamic range (dB) 
50.1 
Typical SNR at nominal 

















15.8 30 30.9 37.6 34.4 29.1 30.9 24.2 
NIRST scan time 42 s (~5s per wavelength) 
DBT scan time 6 s 
3.2 Diffuse image reconstruction of blood contrast phantoms 
A 3D FEM mesh was created in NIRFAST based on the phantom dimensions and the relative 
positions of the sources and detectors. A diffuse, spectrally constrained, chromophore image 
reconstruction was performed on the data from phantoms with 2:1, 3:1 and 4:1 HbT contrast 
in the inclusion relative to the background hemoglobin concentration of 15 µM. A fixed 
regularization value of 0.1 was applied in a modified Newton-type inversion implemented in 
NIRFAST. The scatter properties were defined and fixed in the CW reconstruction process 
and the µs’ values for 1% intralipid solutions were obtained from empirical relations 
described in [21]. 
Since blood is the primary contrast in these phantoms only HbT images are presented 
here. Figure 4 shows the X-Z (Figs. 4(a)-4(d)), X-Y (Figs. 4(e)-4(h)) and Y-Z (Figs. 4(i)-4(l)) 
cross-sectional views of the actual location of the contrast and the reconstructed total 
hemoglobin images in the same views for the 2:1, 3:1 & 4:1 contrast phantoms. Figure 4(m) 
contains a line plot in the X direction across the center of the contrast region in the X-Y 
images shown in Figs. 4(f)-4(h). Figure 4(n) presents a line plot in the Y direction in a region 
beyond the inclusion (see dotted line in Fig. 4e), where some change in recovered hemoglobin 
is observed across the phantom background. 
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Fig. 4. X-Z (a-d), X-Y (e-h), and Y-Z (i-l) cross-sectional views (see Fig. 3(a) for phantom 
coordinate system) of the reconstructed HbT images in the center of the inclusion region for 
the 2:1, 3:1 and 4:1 contrast phantoms. (m) Horizontal (X-direction) line plot through the 
center of the contrast region (see dotted line in (e)) for the three contrast phantoms (A = 2:1; B 
= 3:1; C = 4:1). (n) Vertical (Y-direction) line plot showing HbT concentration through the 
center plane of the phantom inclusion (see dotted line in (e)). 
3.3 Region-guided reconstruction of intralipid/blood contrast phantoms 
The presence of an HbT gradient in the background region did not allow for region-based 
recovery of HbT from the first set of phantom experiments; hence, another set of contrast 
phantoms with 1:1, 2:1 and 3:1 HbT contrasts were cast and were measured on the NIRST-
DBT system. The inclusion-to-background scatter contrast was set to 2:1, and the equivalent 
scattering properties for these regions were assigned based on literature values [21], and were 
constrained to remain fixed during the reconstruction process to minimize potential crosstalk 
between scatter and absorption signal recovery. Care was taken during the setting process to 
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ensure that the phantom molds were placed on a level surface to minimize variations in 
phantom thickness and to maintain mixture homogeneity. 
 
Fig. 5. X-Y cross-sectional views of the reconstructed HbT images for the 1:1 (a), 2:1 (b), and 
3:1 (c) contrast phantoms. (d) Cut-away view of the FEM mesh showing the background and 
inclusion regions. (e) Plot of recovered HbT contrast in the background (solid triangles) and 
inclusion region (solid circles) vs actual HbT concentration in the background and inclusion. 
Linear fits show that the HbT concentration is nearly constant in the background and varies 
linearly in the inclusion as expected. 
Figure 5 shows results from region-guided recovery of total hemoglobin contrast in 1:1, 
2:1 and 3:1 contrast phantoms. Figure 5(d) provides a cut-away view of the FEM mesh and 
the inclusion region inside. Figures 5(a)-5(c) contain X-Y cross-sections of the recovered 
total hemoglobin image through the inclusion region for each contrast phantom. Figure 5(e) 
plots the recovered HbT as a function of the actual values in the phantom inclusion and 
background. 
4. Discussion 
This paper describes the design, development and integration of NIRST into a commercial 
DBT scanner. Agarose-based intralipid and blood contrast phantoms were fabricated to 
demonstrate the imaging capabilities of the NIRST component of this multi-modality 
platform. When no spatial priors were used in the reconstruction process, the recovered HbT 
concentration in the background region was approximately 73% of the actual concentration 
for three contrast cases. The recovered peak HbT concentration in the inclusion region was 
approximately 41%, 29% and 26% of the actual HbT concentrations, respectively. The 
recovered centroid location of the contrast was approximately 6.3, 6.6 and 6.8 cm from the 
edge of the phantom, which is close to the actual location of the inclusion (7 cm from the 
edge). A full-width at half maximum (FWHM) criterion was used to analyze the size of the 
contrast from the Z-plane (depth) images and the recovered sizes were approximately 3.4, 3.2 
and 3.1 cm (which is close to the actual inclusion diameter of 3 cm). The size of the recovered 
contrast appears to be larger than that of the actual contrast in the Z-direction, where it 
extends to the surface, likely due to the more modest imaging resolution in the depth 
direction, which is common in the transmission imaging mode used here. 
An overall gradient in HbT in the Y direction was also observed in the background, which 
is visible in the X-Y cross-sectional images in Fig. 4. Figure 4(n) shows a line plot of HbT 
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concentration along this gradient, which indicates that the magnitude of the effect is similar in 
all three imaged phantoms despite their inclusion contrast differences. The X-Y cross 
sectional images also show that the direction of this gradient is similar and consistent in each 
of the three phantoms. A similar gradient was observed in the raw projection data (not shown 
here) suggesting either a gradient distribution in hemoglobin concentration existed in the 
actual phantom or variation occurred in the phantom thickness in this direction. While the 
occurrence of a gradient distribution in HbT concentration is unlikely with the fabrication 
methods applied, a linear change in phantom thickness could easily be induced if the phantom 
molds were not level during the setting process. Forward data simulations performed in slab 
meshes with varying Z thickness and constant optical properties matching that of the 
measured phantoms indicate that a 2-3 mm change in thickness could cause the magnitude of 
forward data change observed in the experimental phantoms. The large slab phantoms used 
here are soft when cured and are compressible, which likely made it hard to notice this small 
but significant height change. 
In the case of region-guided image reconstructions, the background concentration of HbT 
was consistent and equal to approximately 67% of the actual concentration. The recovered 
HbT concentration in the inclusion region was slightly over-estimated (around 110% of the 
actual concentration) in the 1:1 HbT contrast case, and was approximately 74% of the actual 
concentration in the 2:1 and 3:1 contrast cases. Figure 5(e) also shows that the recovered peak 
HbT concentration in the inclusion region increases linearly with actual HbT concentration, 
while the recovered background HbT concentration remains nearly constant throughout, as 
expected. For the no-HbT contrast case (1:1), the recovered HbT value was overestimated and 
created an artificial contrast. The recovered contrast values are approximately 1:1.6, 1: 2.2 
and 1:3.1 respectively, compared to the actual values of 1:1, 1:2 and 1:3. Even though the 
recovered contrast matches the true contrast values for the 1:2 and 1:3 cases closely, it should 
be noted that the absolute HbT concentrations for the background and inclusion regions were 
equally underestimated by ~25-30% in both these cases. These deviations in reconstructed 
HbT concentration values are likely caused due to a combination of several effects including, 
mismatch in the refractive index between the gelatin background and the liquid inclusions and 
mismatch in the specification of scatter properties obtained from literature recipes [21], which 
could result in a cross-talk between scatter and absorption parameters, and numerical artifacts 
caused by fixing the scatter properties during the CW reconstruction process. However, the 
region-guided approach provided a consistent recovery of hemoglobin parameters in the 
background and inclusion regions overall. 
The optical scan time for single wavelength imaging is currently ~5 s, which is 
comparable to the DBT scan time. However for spectral imaging using 8 wavelengths the 
overall scan time increases to approximately 42 s, as the wavelengths are sequentially 
scanned. Reduction in overall scan time is possible through wavelength multiplexing 
approaches, but the large area silicon photodiodes used here are not fast enough to allow 
implementation of commonly used time or frequency based multiplexing strategies. As an 
alternate, avalanche photodiodes (APD) offer much higher photon sensitivity and have better 
dynamic response, but integration of APDs into this form factor would lead to significantly 
increased instrumentation complexity and cost. APDs are also inherently noisier compared to 
silicon photodiodes, which could impact signal-to-noise ratio (SNR) and dynamic range, so it 
is not readily clear whether an APD based detector panel would offer significant 
improvements in scan time at a comparable SNR to justify increased cost and instrumentation 
complexity. Small scale testing of other types of silicon photodiodes and post-processing 
circuitry are currently underway to optimize the detection panel for the subsequent design 
iteration of the NIRST system. 
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5. Conclusion 
Integration and co-registration of DBT and NIRST imaging allow synergistic structural and 
functional imaging of breast abnormalities, which could improve diagnostic accuracy overall. 
Success with this approach depends on how well the NIRST technology can be integrated into 
existing workflow for clinical DBT imaging. The major focus of this first generation NIRST-
DBT imaging system design was to balance integration and imaging performance with 
instrumentation complexity and cost. Creation of a high sensitivity, multi-element, solid-state 
detector panel, along with a simple, permanently mounted non-contact source scanning 
assembly offers high-speed scanning, compact DBT integration and reduced instrumentation 
complexity. Results from contrast phantom studies demonstrate the ability of the system to 
detect and localize hemoglobin contrast. While the diffuse image reconstructions recovered 
the approximate position and size of the HbT contrast, the quantitative performance in terms 
of actual property values was not optimal. The use of prior information on the size and 
location of the contrast in the reconstruction algorithm improved the quantitative optical 
property performance significantly, which underscores the benefits of dual modality optical 
imaging platforms, such as the one described here. Knowledge of optical scattering properties 
is important to accurate recovery of hemoglobin values. The CW system implemented here is 
not capable of measuring scatter signals directly, but could be augmented with some 
frequency domain (FD) measurements if necessary. Several design approaches are being 
considered, and an important tradeoff is the number of FD measurement channels and 
wavelengths needed for robust sampling of scattering properties across the breast. A separate 
study [22] of scattering properties effects on the quantitative recovery of hemoglobin contrast 
suggests that limited, region-averaged sampling of scatter properties is sufficient for accurate 
reconstruction of hemoglobin contrast. Another interesting approach is to map optical scatter 
properties to tissue density images acquired with DBT. Tissue density is known to affect its 
optical scattering response, but a complete mapping between optical and DBT images is not 
trivial, mainly because DBT images are typically not quantitative. Significant efforts have 
been underway to make DBT imaging quantitative [23, 24], and advances could impact the 
design and integration of DBT coupled optical imaging in the future. 
The phantom imaging experiments described here involved a fixed-size for the inclusions 
and the lateral and depth positions were also fixed. Though these experiments provided an 
initial quantitative assessment of the performance of the imaging instrumentation, a more 
extensive evaluation would generate contrast-detail analyses, where both the size and the 
location of the contrast are changed. The phantom design outlined here is not suitable for this 
type of characterization, which is required for a comprehensive analysis of diagnostic 
performance using standard receiver operating characteristic (ROC) metrics. Currently, a 
multilayer, stackable, spectral resin phantom is being designed in collaboration with the 
Institut National d'Optique (INO, Quebec, Canada) to facilitate the imaging of different 
contrast sizes at multiple depth locations in order to complete this analysis in the future. 
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